{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:21:12Z","timestamp":1791260472279,"version":"4.1.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151346","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:59:48Z","timestamp":1773129588000},"page":"151346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A review on nanostructured chitosan platforms for controlled and targeted delivery of paclitaxel in lung cancer treatment"],"prefix":"10.1016","volume":"354","author":[{"given":"Simranjit","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinkal","family":"Ranch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Bharti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deen","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kundan Kumar","family":"Chaubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4085-8936","authenticated-orcid":false,"given":"Devesh U.","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151346_bb0005","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s12668-024-01461-6","article-title":"Biocompatible chitosan\/starch\/graphene quantum dots\/titanium dioxide nanocomposite: a stimuli-responsive, porous Nanocarrier for prolonged quercetin delivery in lung Cancer treatment","volume":"14","author":"Tahamtan","year":"2024","journal-title":"BioNanoScience"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151346_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/life13051194","article-title":"Functional outcomes and safety profile of trans-foveal subthreshold micropulse laser in persistent central serous chorioretinopathy","volume":"13","author":"Kiraly","year":"2023","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5114\/wo.2021.103829","article-title":"Epidemiology of lung cancer","volume":"25","author":"Thandra","year":"2021","journal-title":"Wsp\u00f3\u0142czesna Onkol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151346_bb0020","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1039\/D3NR05656B","article-title":"Nanotherapeutic approaches for delivery of long non-coding RNAs: an updated review with emphasis on cancer","volume":"16","author":"Davodabadi","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.msec.2017.04.049","article-title":"Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel","volume":"78","author":"He","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151346_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16080969","article-title":"The role of inhaled chitosan-based nanoparticles in lung cancer therapy","volume":"16","author":"Silva","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0035","doi-asserted-by":"crossref","DOI":"10.37349\/ebmx.2025.101342","article-title":"Polymer-based nanoparticles for cancer theranostics: advances, challenges, and future perspectives","volume":"2","author":"Shanahan","year":"2025","journal-title":"Exploration of BioMat-X"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0040","doi-asserted-by":"crossref","unstructured":"Zhang J, Li Y, Guo S, Zhang W, Fang B, Wang SJFiP. Moving beyond traditional therapies: the role of nanomedicines in lung cancer. 2024;15:1363346.","DOI":"10.3389\/fphar.2024.1363346"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02163-z","article-title":"Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers","volume":"23","author":"Kesharwani","year":"2024","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151346_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11072080","article-title":"Evaluation of folate-functionalized nanoparticle drug delivery systems\u2014effectiveness and concerns","volume":"11","author":"Ibrahim","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151346_bb0055","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s12668-024-01593-9","article-title":"Synthesis of Nanocarrier based on chitosan\/agarose biopolymers containing carbon quantum dot doped titanium dioxide for targeted delivery of 5-fluorouracil for brain Cancer treatment","volume":"14","author":"Masnavi","year":"2024","journal-title":"BioNanoScience"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120510","article-title":"Carbohydrate polymer-based nanocomposites for breast cancer treatment","volume":"304","author":"Moghaddam","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0065","doi-asserted-by":"crossref","unstructured":"Garg U, Chauhan S, Nagaich U, Jain NJApb. Current advances in chitosan nanoparticles based drug delivery and targeting. 2019;9(2):195.","DOI":"10.15171\/apb.2019.023"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151346_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/polym17111453","article-title":"Chitosan nanoparticle-based drug delivery systems: advances, challenges, and future perspectives","volume":"17","author":"Stefanache","year":"2025","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2024.100040","article-title":"Chitosan nanoparticle delivery systems: an effective approach to enhancing efficacy and safety of anticancer drugs","volume":"3","author":"Grewal","year":"2024","journal-title":"Nano TransMed"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12668-024-01638-z","article-title":"Chitosan functionalized skin-adhesive formulation for ergotamine delivery in melanoma treatment","volume":"15","author":"Azhar","year":"2024","journal-title":"BioNanoScience"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010170","article-title":"Evaluation of the mucoadhesive properties of chitosan-based microstructured lipid carrier (CH-MLC)","volume":"14","author":"Guerini","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144656","article-title":"Precision nanophytomedicine: alginate-chitosan nanogels encapsulating Olea ferruginea ethyl acetate fraction for enhanced cardiovascular protection","volume":"318","author":"Sharif","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151346_bb0095","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3390\/molecules30061297","article-title":"Chitosan and its derivatives as nanocarriers for drug delivery","volume":"30","author":"Biswas","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0100","article-title":"Innovative chitosan-polyacrylic acid-MoS2 nanocomposite for enhanced and pH-responsive quercetin delivery","volume":"39","author":"Pourmadadi","year":"2024","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111442","article-title":"Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel","volume":"119","author":"Wang","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.151346_bb0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2015.07.022","article-title":"Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer","volume":"492","author":"Yuan","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2005.09.026","article-title":"Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice","volume":"110","author":"Obara","year":"2005","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151346_bb0120","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/s41401-020-00594-0","article-title":"Chitosan oligosaccharide modified liposomes enhance lung cancer delivery of paclitaxel","volume":"42","author":"Miao","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.msec.2016.06.025","article-title":"Targeted delivery and controlled release of paclitaxel for the treatment of lung cancer using single-walled carbon nanotubes","volume":"68","author":"Yu","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0130","doi-asserted-by":"crossref","first-page":"4607945","DOI":"10.1155\/2018\/4607945","article-title":"Biodegradable alginate-chitosan hollow Nanospheres for Codelivery of doxorubicin and paclitaxel for the effect of human lung Cancer A549 cells","volume":"2018","author":"Tao","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0135","doi-asserted-by":"crossref","unstructured":"Mohiuddin M, Kasahara KJCg, proteomics. The mechanisms of the growth inhibitory effects of paclitaxel on gefitinib-resistant non-small cell lung cancer cells. 2021;18(5):661\u201373.","DOI":"10.21873\/cgp.20288"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151346_bb0140","first-page":"645","volume":"18","author":"Mohiuddin","year":"2021","journal-title":"Proteomics Paclitaxel impedes EGFR-mutated PC9 cell growth via reactive oxygen species-mediated DNA damage and EGFR\/PI3K\/AKT\/mTOR signaling pathway suppression"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151346_bb0145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10495-022-01750-z","article-title":"Mechanisms of cancer cell death induction by paclitaxel: an updated review","volume":"27","author":"Zhao","year":"2022","journal-title":"Apoptosis"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151346_bb0150","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1080\/03639045.2017.1318895","article-title":"Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells","volume":"43","author":"Jiang","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40262-017-0563-z","article-title":"Clinical pharmacokinetics of paclitaxel monotherapy: an updated literature review","volume":"57","author":"Stage","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key genes and molecular mechanisms related to paclitaxel resistance","volume":"24","author":"AIJCCI","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151346_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26030901","article-title":"Multicore, SDS-based polyelectrolyte nanocapsules as novel nanocarriers for Paclitaxel to reduce cardiotoxicity by protecting the mitochondria","volume":"26","author":"Szwed","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80283-8","article-title":"Formulation and evaluation of cetuximab functionalized phospholipid modified nanocrystals of paclitaxel for non-small cell lung cancer therapy","volume":"14","author":"Kumar","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151346_bb0175","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41401-023-01219-y","article-title":"Targeted inhibition of the HNF1A\/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13008-023-00093-8","article-title":"Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells","volume":"18","author":"Maharati","year":"2023","journal-title":"Cell Div"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151346_bb0185","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.3390\/ijms12074395","article-title":"Enabling anticancer therapeutics by nanoparticle carriers: the delivery of paclitaxel","volume":"12","author":"Liu","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15012-5","article-title":"Chemodrug delivery using integrintargeted PLGA-chitosan nanoparticle for lung cancer therapy","volume":"7","author":"Babu","year":"2017","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.151346_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/polym13193256","article-title":"Chitosan: an overview of its properties and applications","volume":"13","author":"Aranaz","year":"2021","journal-title":"Polymers"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151346_bb0200","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/gels8070393","article-title":"Chitosan: sources, processing and modification techniques","volume":"8","author":"Pellis","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tifs.2020.11.027","article-title":"Preparation and biological activities of chitosan oligosaccharides","volume":"107","author":"Benchamas","year":"2021","journal-title":"Trends Food Sci. Technol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.151346_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39879","article-title":"Stability, challenges, and prospects of chitosan for the delivery of anticancer drugs and tissue regenerative growth factors","volume":"10","author":"Rahman","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addr.2013.07.010","article-title":"Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation","volume":"67","author":"Rokstad","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151346_bb0220","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0225","series-title":"Pharmaceutical Regulation of Nanomedicines: Principles and Challenges: Universidade de Lisboa (Portugal)","author":"Lousa","year":"2024"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.151346_bb0230","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.3390\/polym15183849","article-title":"Advancements in chitosan-based nanoparticles for pulmonary drug delivery","volume":"15","author":"Zacaron","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0235","series-title":"Physico-chemical aspects of dosage forms and biopharmaceutics","first-page":"367","article-title":"World Health Organization and International Council for Harmonization Guidelines for \u201cGood Manufacturing Practices\u201d","author":"Sahoo","year":"2024"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151346_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/md21040211","article-title":"Chitosan nanoparticles-based cancer drug delivery: application and challenges","volume":"21","author":"Sachdeva","year":"2023","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0245","article-title":"Chitosan in biomedicine: a comprehensive review of recent developments","volume":"8","author":"Yadav","year":"2024"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116800","article-title":"A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers","volume":"250","author":"Rasul","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0255","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.2147\/IJN.S472433","article-title":"Chitosan nanoparticles for targeted cancer therapy: a review of stimuli-responsive, passive, and active targeting strategies","author":"Al-Shadidi","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0260","series-title":"Functionalization of Chitosan-Cellulose: \u535a\u58eb\u8ad6\u6587","author":"Panchabashini","year":"2024"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/acs.biomac.0c00663","article-title":"Thiolated chitosans: a multi-talented class of polymers for various applications","volume":"22","author":"Federer","year":"2020","journal-title":"Biomacromolecules"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.151346_bb0270","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.3390\/ijms21186617","article-title":"Quaternary ammonium chitosans: the importance of the positive fixed charge of the drug delivery systems","volume":"21","author":"Fabiano","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0275","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10717544.2020.1716878","article-title":"Self-assembled chitosan\/phospholipid nanoparticles: from fundamentals to preparation for advanced drug delivery","volume":"27","author":"Ma","year":"2020","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1061186X.2011.611518","article-title":"Recent advances in ligand targeted therapy","volume":"20","author":"Trapani","year":"2012","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151346_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020473","article-title":"Chitosan nanoparticle-based system: a new insight into the promising controlled release system for lung cancer treatment","volume":"27","author":"Yee Kuen","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151346_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/md20050335","article-title":"Multiple roles of chitosan in mucosal drug delivery: an updated review","volume":"20","author":"Mura","year":"2022","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0295","article-title":"Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer","volume":"14","author":"Anjum","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/polysaccharides6010011","article-title":"Hydrophobic chitosan derivatives for gene and drug delivery in cancer therapies","volume":"6","author":"Poshina","year":"2025","journal-title":"Polysaccharides"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40883-023-00310-4","article-title":"Chitosan-based drug conjugated nanocomposites: advances and innovation in cancer therapy","volume":"10","author":"Kumar","year":"2024","journal-title":"Regenerative Engineering and Translational Medicine."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2022.1067144","article-title":"Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: current progress and challenges","volume":"4","author":"Das","year":"2023","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0315","series-title":"Chitosan Nanocomposites: Bionanomechanical Applications","first-page":"27","article-title":"Biological and Chemical Aspects of Chitosan","author":"Butnariu","year":"2023"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121839","article-title":"Chitosan-based nanosystems for cancer diagnosis and therapy: stimuli-responsive, immune response, and clinical studies","volume":"330","author":"Moghaddam","year":"2024","journal-title":"Carbohydr. Polym."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151346_bb0325","doi-asserted-by":"crossref","DOI":"10.1007\/s42114-023-00768-4","article-title":"Chitosan decorated cobalt zinc ferrite nanoferrofluid composites for potential cancer hyperthermia therapy: anti-cancer activity, genotoxicity, and immunotoxicity evaluation","volume":"6","author":"Sharifi","year":"2023","journal-title":"Adv. Compos. Hybrid Mater."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151346_bb0330","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2174\/1567201811666140609154949","article-title":"Paclitaxel formulations: challenges and novel delivery options","volume":"11","author":"Nehate","year":"2014","journal-title":"Curr. Drug Deliv."},{"issue":"05","key":"10.1016\/j.ijbiomac.2026.151346_bb0335","doi-asserted-by":"crossref","first-page":"1530004","DOI":"10.1142\/S1793292015300042","article-title":"Nanoscale drug delivery systems: a current review on the promising paclitaxel formulations for future cancer therapy","volume":"10","author":"Fang","year":"2015","journal-title":"Nano"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151346_bb0340","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1039\/D1MA00961C","article-title":"Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy","volume":"3","author":"Raza","year":"2022","journal-title":"Materials Advances."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151346_bb0345","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5530\/jyp.2018.10.62","article-title":"Nanoparticles for the treatment of lung cancers","volume":"10","author":"Sivarajakumar","year":"2018","journal-title":"J. Young Pharm."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0350","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ijbiomac.2017.02.030","article-title":"Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan","volume":"98","author":"Gupta","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0355","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1556-276X-8-66","article-title":"Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer","volume":"8","author":"Jiang","year":"2013","journal-title":"Nanoscale Res. Lett."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151346_bb0360","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1021\/bm2010774","article-title":"Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration","volume":"12","author":"Lv","year":"2011","journal-title":"Biomacromolecules"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151346_bb0365","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jps.21487","article-title":"Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates","volume":"98","author":"Yang","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151346_bb0370","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/acs.molpharmaceut.7b00846","article-title":"New folate-grafted chitosan derivative to improve delivery of paclitaxel-loaded solid lipid nanoparticles for lung tumor therapy by inhalation","volume":"15","author":"Rosiere","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0375","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.colsurfb.2016.08.059","article-title":"Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells","volume":"148","author":"Nag","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0380","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/10717544.2017.1378938","article-title":"In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma","volume":"24","author":"Xie","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0385","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.2147\/IJN.S406415","article-title":"Lipid nanocarrier-based drug delivery systems: therapeutic advances in the treatment of lung cancer","author":"Kim","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.151346_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/app14156759","article-title":"Targeted lipid-based drug delivery Systems for Lung Cancer Therapy","volume":"14","author":"Apostolou","year":"2024","journal-title":"Appl. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151346_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30290","article-title":"Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: in vitro and in vivo investigation","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151346_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/polym13030477","article-title":"Micellar drug delivery systems based on natural biopolymers","volume":"13","author":"Atanase","year":"2021","journal-title":"Polymers (Basel)."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151346_bb0405","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.biomaterials.2007.11.029","article-title":"Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel","volume":"29","author":"Zhang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.22159\/ijcpr.2021v13i1.40823","article-title":"Hydrogels the three dimensional networks: a review","author":"M","year":"2021","journal-title":"Int. J. Curr. Pharm. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151346_bb0415","article-title":"Mechanical properties of carbon nanotubes (CNTs): a review","volume":"8","year":"2022","journal-title":"Eurasian Journal of Science and Engineering."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151346_bb0420","first-page":"1707","article-title":"In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle","volume":"23","author":"Rezazadeh","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0425","series-title":"Drug Delivery with Targeted Nanoparticles","first-page":"97","article-title":"Ligands and Receptors for Targeted Delivery of Nanoparticles: Recent Updates and Challenges","author":"Javia","year":"2021"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151346_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030722","article-title":"Vitamin E TPGS-based nanomedicine, nanotheranostics, and targeted drug delivery: past, present, and future","volume":"15","author":"Mehata","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151346_bb0435","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7439.1000164","article-title":"Paclitaxel nano-delivery systems: a comprehensive review","volume":"4","author":"Ma","year":"2013","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151346_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17070888","article-title":"Nanotechnology approaches for mitigating biologic immunogenicity: a literature review","volume":"17","author":"Alanazi","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0445","article-title":"Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer","volume":"29","author":"Qiao","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0450","series-title":"Characterization and biology of nanomaterials for drug delivery","first-page":"477","article-title":"Nanotechnology and Nanomedicine in Market: A Global Perspective on Regulatory Issues","author":"Devasahayam","year":"2019"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151346_bb0455","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","article-title":"Understanding pharmaceutical quality by design","volume":"16","author":"Yu","year":"2014","journal-title":"AAPS J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151346_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21903","article-title":"Efficacy and safety of nanoparticle albumin-bound paclitaxel in advanced nonsmall cell lung cancer: a systematic review and meta-analysis of clinical trials and observational studies","volume":"9","author":"Suwannasom","year":"2023","journal-title":"Heliyon"},{"issue":"35","key":"10.1016\/j.ijbiomac.2026.151346_bb0465","doi-asserted-by":"crossref","first-page":"25149","DOI":"10.1039\/D4RA03911D","article-title":"Biopolymeric nanocarriers in cancer therapy: unleashing the potency of bioactive anticancer compounds for enhancing drug delivery","volume":"14","author":"Hadkar","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0470","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1039\/D5PM00095E","article-title":"Chitosan-based nano-objects for drug delivery: a review of their chemical modifications, supramolecular organization and biological fate","volume":"2","author":"Parchen","year":"2025","journal-title":"RSC Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151346_bb0475","first-page":"135","article-title":"Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial","volume":"4","author":"Li","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151346_bb0480","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-024-02948-x","article-title":"Chitosan-based nanoformulations: preclinical investigations, theranostic advancements, and clinical trial prospects for targeting diverse pathologies","volume":"25","author":"Yadav","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151346_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113467","article-title":"Paclitaxel-loaded magnetic nanoparticles based on biotinylated N-palmitoyl chitosan: synthesis, characterization and preliminary in vitro studies","volume":"26","author":"Ursachi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107622","article-title":"SPRAY-DRIED solid inhalable N-acetylcysteine microparticles: preparation and mucolytic activity testing","volume":"114","author":"Ho\u0159avov\u00e1","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.151346_bb0495","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus chemotherapy for squamous non\u2013small-cell lung cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151346_bb0500","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non\u2013small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151346_bb0505","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin\u2013paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.151346_bb0510","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","article-title":"Nivolumab plus ipilimumab in advanced non\u2013small-cell lung cancer","volume":"381","author":"Hellmann","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151346_bb0515","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00280-019-03843-0","article-title":"A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer","volume":"84","author":"Kato","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151346_bb0520","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.tranon.2019.01.008","article-title":"Phase II study of a bi-weekly chemotherapy regimen of combined liposomal paclitaxel and Nedaplatin for the treatment of advanced squamous cell lung Cancer","volume":"12","author":"Lv","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0525","series-title":"Nanocapsules coated with chitosan and use thereof","author":"Choi","year":"2022"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0530","series-title":"FERNANDES JC, JUNIOR AMM, DE SOUZA RHFV, Benderdour M","author":"Tiera","year":"2024"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0535","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijbiomac.2020.12.005","article-title":"Chitosan: a review of sources and preparation methods","volume":"169","author":"Kou","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100048","article-title":"Scale-up polymeric-based nanoparticles drug delivery systems: development and challenges","volume":"7","author":"Herdiana","year":"2022","journal-title":"OpenNano"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151346_bb0545","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine scale-up technologies: feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0550","first-page":"62","article-title":"Chitosan-based formulations for therapeutic applications. A recent overview","volume":"32","author":"Gonciarz","year":"2025"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0555","series-title":"Pharmaceutical process engineering and scale-up principles","first-page":"173","article-title":"Scale-Up of Nanoparticle Manufacturing Process","author":"Fernandes","year":"2023"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0560","doi-asserted-by":"crossref","unstructured":"Silva AC, Costa MP, Zacaron TM, Ferreira KCB, Braz WR, Fabri RL, et al. The role of inhaled chitosan-based nanoparticles in lung cancer therapy. Pharmaceutics 2024;16(8):969.","DOI":"10.3390\/pharmaceutics16080969"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151346_bb0565","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/0113894501301747240417103321","article-title":"Chitosan-based nanocarriers for pulmonary and intranasal drug delivery systems: a comprehensive overview of their applications","volume":"25","author":"Alwahsh","year":"2024","journal-title":"Curr. Drug Targets"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151346_bb0570","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/00914037.2020.1869737","article-title":"Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy","volume":"71","author":"Ahmad","year":"2022","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104196","article-title":"Chitosan-based nano drug delivery system for lung cancer","volume":"81","author":"Kazmi","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151346_bb0580","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/molecules27020473","article-title":"Chitosan nanoparticle-based system: a new insight into the promising controlled release system for lung cancer treatment","volume":"27","author":"Yee Kuen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.151346_bb0585","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.2147\/IJN.S554821","article-title":"Bridging the gap: the role of advanced formulation strategies in the clinical translation of nanoparticle-based drug delivery systems","author":"Herdiana","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151346_bb0590","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/ph17081059","article-title":"Nanoparticle-based drug delivery systems in inhaled therapy: improving respiratory medicine","volume":"17","author":"Cojocaru","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151346_bb0595","article-title":"Global research trends and emerging hotspots in nano-drug delivery systems for lung cancer: a comprehensive bibliometric analysis (1998\u20132024)","volume":"16","author":"Yu","year":"2025","journal-title":"Discov. Oncol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151346_bb0600","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/pharmaceutics16070868","article-title":"Gene therapy with chitosan nanoparticles: modern formulation strategies for enhancing cancer cell transfection","volume":"16","author":"Antoniou","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026012729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026012729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:50:01Z","timestamp":1774288201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026012729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":120,"alternative-id":["S0141813026012729"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151346","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on nanostructured chitosan platforms for controlled and targeted delivery of paclitaxel in lung cancer treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151346"}}